No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy

Schober, Sebastian Johannes; Hallmen, Erika; Ressle, Florian; Gassmann, Hendrik; Prexler, Carolin; Wawer, Angela; von Luettichau, Irene; Ladenstein, Ruth; Kazanowska, Bernarda; Ljungman, Gustaf; Niggli, Felix; Lohi, Olli; Hauer, Julia; Gruhn, Bernd; Klingebiel, Thomas; Bader, Peter; Burdach, Stefan; Lang, Peter; Sparber-Sauer, Monika; Koscielniak, Ewa; Thiel, Uwe

No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy

Autor(en):

Schober, Sebastian Johannes; Hallmen, Erika; Ressle, Florian; Gassmann, Hendrik; Prexler, Carolin; Wawer, Angela; von Luettichau, Irene; Ladenstein, Ruth; Kazanowska, Bernarda; Ljungman, Gustaf; Niggli, Felix; Lohi, Olli; Hauer, Julia; Gruhn, Bernd; Klingebiel, Thomas; Bader, Peter; Burdach, Stefan; Lang, Peter; Sparber-Sauer, Monika; Koscielniak, Ewa; Thiel, Uwe

Tübinger Autor(en):

Lang, Peter
Sparber-Sauer, Monika
Koscielniak, Ewa

Erschienen in:

Frontiers in Oncology (2022), Bd. 12, Article 878367

Verlagsangabe:

Frontiers Media Sa

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.3389/fonc.2022.878367

ISSN:

2234-943X